Health Economics for Non-Health-Economists 2015

DAY 1 Welcome and General Introduction Health Economic Evaluations: Why and How Exercises on QALYs Health Economic Modelling – Commonly Used Models Cost Analysis and Budget Impact Analysis. Exercise on budget impact Guidelines for the Conduct and Reporting of Health Economic Evaluation BREAK OUT SESSION: how to distinguish a good health economic paper from a poor quality paper. DAY 2 Prospective Health Economic Evaluations Use of Health Economic Evaluations in Healthcare Decision Making Health Economic Evaluation in a Pharmaceutical Drug's Life Cycle BREAK OUT SESSION: Developing together a health economic strategy Final Discussion and Close -----------------------------------------------------------------Testimonials from past participants: 'If anyone wants to get a good background on Health Economics, or just better understanding of this topic, Prof. Lieven Annemans is the right teacher. He presents a unique mixture of great professional knowledge, passion, industry experience and a sense of humor. During this 2-day course I received a lot information on Health Economics to digest and to return to in the future. Well-structured and perfectly delivered. Thank you. And a big thank you to C.E.L.forpharma for making this course happen and for the excellent organization.' Slawomir Lazarewicz, Senior Director Global Medical Information, Novartis - Switzerland (June 2015) "Very good course, well organised, and executed by an excellent expert with a high level of knowledge and great presentation skills. Summarised: this course is good value for money, even though not cheap, this is clearly a cost-effective course!" Kai Strohtmann, Senior Director Commercial Assessment, Grünenthal - Germany (Feb 2015) "Very good training with a talented professor. I recommend this course to all people who want to learn more about HEOR." Baptiste Dupuy, EU Brand Manager, Pfizer - France (December 2014)